Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 181(2): 1429-37, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18606697

ABSTRACT

The prototypic formyl peptide N-formyl-Met-Leu-Phe (fMLF) is a major chemoattractant found in Escherichia coli culture supernatants and a potent agonist at human formyl peptide receptor (FPR) 1. Consistent with this, fMLF induces bactericidal functions in human neutrophils at nanomolar concentrations. However, it is a much less potent agonist for mouse FPR (mFPR) 1 and mouse neutrophils, requiring micromolar concentrations for cell activation. To determine whether other bacteria produce more potent agonists for mFPR1, we examined formyl peptides from Listeria monocytogenes and Staphylococcus aureus for their abilities to activate mouse neutrophils. A pentapeptide (N-formyl-Met-Ile-Val-Ile-Leu (fMIVIL)) from L. monocytogenes and a tetrapeptide (N-formyl-Met-Ile-Phe-Leu (fMIFL)) from S. aureus were found to induce mouse neutrophil chemotaxis at 1-10 nM and superoxide production at 10-100 nM, similar to the potency of fMLF on human neutrophils. Using transfected cell lines expressing mFPR1 and mFPR2, which are major forms of FPRs in mouse neutrophils, we found that mFPR1 is responsible for the high potency of fMIVIL and fMIFL. In comparison, activation of mFPR2 requires micromolar concentrations of the two peptides. Genetic deletion of mfpr1 resulted in abrogation of neutrophil superoxide production and degranulation in response to fMIVIL and fMIFL, further demonstrating that mFPR1 is the primary receptor for detection of these formyl peptides. In conclusion, the formyl peptides from L. monocytogenes and S. aureus are approximately 100-fold more potent than fMLF in activating mouse neutrophils. The ability of mFPR1 to detect bacterially derived formyl peptides indicates that this important host defense mechanism is conserved in mice.


Subject(s)
Chemotactic Factors/immunology , Chemotaxis, Leukocyte , Listeria monocytogenes/immunology , Neutrophils/immunology , Oligopeptides/immunology , Receptors, Formyl Peptide/metabolism , Staphylococcus aureus/immunology , Animals , Mice , Mice, Inbred C57BL , Mice, Knockout , N-Formylmethionine Leucyl-Phenylalanine/immunology , Neutrophil Activation , Neutrophils/metabolism , Oligopeptides/metabolism , Rats , Receptors, Formyl Peptide/deficiency , Receptors, Formyl Peptide/immunology , Transfection
2.
Am J Physiol Renal Physiol ; 286(5): F988-96, 2004 May.
Article in English | MEDLINE | ID: mdl-15075195

ABSTRACT

Ischemic-induced cell injury results in rapid duration-dependent actin-depolymerizing factor (ADF)/cofilin-mediated disruption of the apical microvilli microfilament cores. Because intestinal microvillar microfilaments are bound and stabilized in the terminal web by the actin-binding protein tropomyosin, we questioned whether a protective effect of tropomyosin localization to the terminal web of the proximal tubule microfilament cores is disrupted during ischemic injury. With tropomyosin-specific antibodies, we examined rat cortical sections under physiological conditions and following ischemic injury by confocal microscopy. In addition, Western blot analysis of cortical extracts and urine was undertaken. Our studies demonstrated the presence of tropomyosin isoforms in the proximal tubule microvillar terminal web under physiological conditions and their dissociation in response to 25 min of ischemic injury. This correlated with the excretion of tropomyosin-containing plasma membrane vesicles in urine from ischemic rats. In addition, we noted increased tropomyosin Triton X-100 solubility following ischemia in cortical extracts. These studies suggest tropomyosin binds to and stabilizes the microvillar microfilament core in the terminal web under physiological conditions. With the onset of ischemic injury, we propose that tropomyosin dissociates from the microfilament core providing access to microfilaments in the terminal web for F-actin binding, severing and depolymerizing actions of ADF/cofilin proteins.


Subject(s)
Actin Cytoskeleton/metabolism , Ischemia/metabolism , Kidney Tubules, Proximal/metabolism , Microvilli/metabolism , Tropomyosin/metabolism , Actin Depolymerizing Factors , Actins/metabolism , Animals , Destrin , Leucine Zippers/physiology , Male , Microfilament Proteins/metabolism , Rats , Rats, Sprague-Dawley , Urine
3.
Am J Physiol Renal Physiol ; 284(4): F852-62, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12620926

ABSTRACT

Ischemic injury induces actin cytoskeleton disruption and aggregation, but mechanisms affecting these changes remain unclear. To determine the role of actin-depolymerizing factor (ADF)/ cofilin participation in ischemic-induced actin cytoskeletal breakdown, we utilized porcine kidney cultured cells, LLC-PK(A4.8), and adenovirus containing wild-type (wt), constitutively active, and inactive Xenopus ADF/cofilin linked to green fluorescence protein [XAC(wt)-GFP] in an ATP depletion model. High adenoviral infectivity (70%) in LLC-PK(A4.8) cells resulted in linearly increasing XAC(wt)-GFP and phosphorylated (p)XAC(wt)-GFP (inactive) expression. ATP depletion rapidly induced dephosphorylation, and, therefore, activation, of endogenous pcofilin as well as pXAC(wt)-GFP in conjunction with the formation of fluorescent XAC(wt)-GFP/actin aggregates and rods. No significant actin cytoskeletal alterations occurred with short-term ATP depletion of LLC-PK(A4.8) cells expressing GFP or the constitutively inactive mutant XAC(S3E)-GFP, but cells expressing the constitutively active mutant demonstrated nearly instantaneous actin disruption with aggregate and rod formation. Confocal image three-dimensional volume reconstructions of normal and ATP-depleted LLC-PK(A4.8) cells demonstrated that 25 min of ATP depletion induced a rapid increase in XAC(wt)-GFP apical and basal signal in addition to XAC-GFP/actin aggregate formation. These data demonstrate XAC(wt)-GFP participates in ischemia-induced actin cytoskeletal alterations and determines the rate and extent of these ATP depletion-induced cellular alterations.


Subject(s)
Actins/metabolism , Cytoskeleton/metabolism , Kidney/metabolism , Microfilament Proteins/metabolism , Actin Depolymerizing Factors , Adenosine Triphosphate/metabolism , Adenoviridae/genetics , Animals , Antimycin A/pharmacology , Cell Line , Cell Membrane/metabolism , Cytoskeleton/drug effects , Destrin , Gene Transfer Techniques , Green Fluorescent Proteins , Kidney/cytology , Kidney/drug effects , LLC-PK1 Cells , Luminescent Proteins/genetics , Mice , Microfilament Proteins/genetics , Microscopy, Fluorescence , Mutagenesis, Site-Directed , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Transport/drug effects , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Swine , Xenopus
SELECTION OF CITATIONS
SEARCH DETAIL
...